Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium folate |
Is a |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid-containing product |
Is a |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetrahydrofolic acid |
Is a |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydrofolic acid |
Is a |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid measurement (procedure) |
Has measured component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Plasma folate measurement |
Has measured component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental folic acid poisoning |
Causative agent (attribute) |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional folic acid poisoning |
Causative agent (attribute) |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par l'acide folique d'intention indéterminée |
Causative agent (attribute) |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Iron and folic acid adverse reaction |
Causative agent (attribute) |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid adverse reaction |
Causative agent (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid overdose (disorder) |
Causative agent (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental folic acid overdose (disorder) |
Causative agent (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional folic acid overdose |
Causative agent (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de acide folique d'intention indéterminée |
Causative agent (attribute) |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning by folic acid |
Causative agent (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid measurement, serum |
Has measured component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid measurement, RBC |
Has measured component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Whole blood folate measurement |
Has measured component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Blood folate NOS |
Has measured component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid radioimmunoassay (procedure) |
Component |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Radiobioassay - folic acid |
Component |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid measurement (procedure) |
Component |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Plasma folate measurement |
Component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Folic acid measurement, serum |
Component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Folic acid measurement, RBC |
Component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Whole blood folate measurement |
Component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Blood folate NOS |
Component |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid allergy |
Causative agent (attribute) |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid 400 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid 2.5mg/5mL sugar free syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid 400micrograms/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely folic acid 400 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid 300micrograms/5mL sugar-free syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid 4mg/5mL sugar-free syrup (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid 5mg/5mL sugar-free syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous fumarate 324 mg and folic acid 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid + iron 0.8mg/15mg drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid + iron 1mg/100mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leucovorin preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folinic acid preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product acting as folic acid supplement (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iron+folic acid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ferrous sulfate+folic acid 150mg/500micrograms m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous sulfate+folic acid 325mg/350micrograms m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferric ammonium citrate+folic acid 80mg/500micrograms/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous sulfate+folic acid 160mg/400micrograms m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferric ammonium citrate+folic acid 80mg/2.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ascorbic acid 10 milligram and ferrous gluconate 250 milligram and folic acid 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous fumarate 322 mg and folic acid 350 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cyanocobalamin and folic acid and vitamin B6 compound (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Folinic acid 50mg/5mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 100mg/10mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 25mg/2.5mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 10mg/mL injection solution 17.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 350mg/35mL injection solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 7.5mg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 300mg/30mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 3mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 15mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 30mg injection (pdr for recon) (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 3mg/mL injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 100mg/2mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 400mg/8mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 900mg/18mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
acide lévofolinique 50 mg/5 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 50mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid 15mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Folinic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental folic acid poisoning |
Causative agent (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional folic acid poisoning |
Causative agent (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Iron and folic acid allergy |
Causative agent (attribute) |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ferrous fumarate and folic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ferrous gluconate- and folic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ferrous sulfate and folic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ferric ammonium citrate and folic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Levomefolic acid |
Is a |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Administration of prophylactic folic acid (procedure) |
Direct substance |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely folic acid 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Administration of prophylactic folic acid (procedure) |
Direct substance |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid allergy |
Causative agent (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyanocobalamin + folic acid |
Is a |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous salt + folic acid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ferrous salt and folic acid in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing folic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ferrous fumarate 322 mg and folic acid 350 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ascorbic acid 10 milligram and ferrous gluconate 250 milligram and folic acid 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid 100 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid 400 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Folic acid 400 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely folic acid 400 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |